← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2017Last known activity
Mar 24, 2026
Timeline
2010s
- May 14, 2015
Denali Therapeutics Inc.— Founded
Drugs by trial phase (10 distinct, 22 trials)
Phase 3 (5 own, 0 via acquisition)
Indications
Recent trials (37)
- NCT06602193Lead sponsorPhase 2Oct 24, 2024
- NCT06602193OfficialPhase 2Oct 24, 2024
- NCT06281158Lead sponsorPhase 1Mar 1, 2024
- NCT06281158OfficialPhase 1Mar 1, 2024
- NCT06181136Lead sponsorPhase 1/Phase 2Dec 7, 2023
- NCT06181136Study directorPhase 1/Phase 2Dec 7, 2023
- NCT06075537Study directorPhase 2/Phase 3Sep 20, 2023
- NCT06075537Lead sponsorPhase 2/Phase 3Sep 20, 2023
- NCT05842941CollaboratorPhase 2/Phase 3May 24, 2023
- NCT05418673CollaboratorPhase 3Aug 26, 2022
- NCT05371613Lead sponsorPhase 2/Phase 3Jul 21, 2022
- NCT05371613Study directorPhase 2/Phase 3Jul 21, 2022
- NCT05450549Study directorPhase 1Jul 14, 2022
- NCT05450549Lead sponsorPhase 1Jul 14, 2022
- NCT05348785CollaboratorPhase 2Apr 19, 2022
Details
- Founded
- San Francisco, CA, US May 14, 2015
- Last known activity
- Mar 24, 2026